Professor Richard Boyd is a Director of Magellan Pty Ltd. Professor Boyd is the Director of Monash Immunology and Stem Cell Laboratories (‘MISCL’) at Monash University in Melbourne. Monash University is Australia’s largest university with a student population .
Professor Boyd has directed the research that has led to the development of much of the technology of Magellan.
Professor Boyd directs the research of in excess of 100 ‘stem cell’ scientists at MISCL. A major focus of Richard’s work over the last several years has been in regard to therapeutic applications for adult mesenchymal stem cells – particularly in the veterinary setting.
Professor Richard Boyd was instrumental in dev.eloping the link between sex steroids and thymic atrophy (decline in the functionality of the thymus – the organ which produces all of the body’s T Cells). The “Boyd Thymus – T Cell” technology is targeted at the rejuvenation of the thymus in adults – and a resultant increase in the output of new naive T Cells. Professor Boyd has played an active role in the commercialization of the technology
Professor Boyd is an immunologist by background, and completed his BSc at Monash University in 1972 majoring in Biochemistry and Genetics. In 1977 he was awarded his PhD from Monash University and undertook his Postdoctoral studies at the University of Innsbruck, Austria. In 1983 he returned to Monash University as one of four recipients of Commonwealth Commemorative Postdoctoral Research Fellowships.